Haematology 15 - Bone Marrow Transplant Flashcards

(23 cards)

1
Q

Which CD marker is expressed on haematopoietic stem cells?

A

CD34

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How is patient’s room pressure adjusted to prevent infection during BM transplant?

A

Make it a higher pressure than corridor so that air flows out rather than in

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Which patients can receive umbilical cord blood cells?

A

Only children - as you can only harvest a small volume so patient needs to be of a low weight

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are bone marrow transplant donors matched on?

A
tissue type (HLA type) 
HLA-A/B/C (class I) - present peptides to CD8+ 

HLA-DP/DQ/DR (class II) - present peptides to CD4+

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the probability of having an HLA match with a sibling?

A

1 in 4 chance of matching with each sibling
1-(3/4) number of siblings

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Serological vs dna HLA testing

A
  • serology = low resolution matching (broad group)
  • DNA = high resolution matching
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Recall the process of autologous transplant

A
  • GCSF given (stimulates stem cell release into bloods)
  • obtain a CD34+ cells from BM (stem cells) → preserve and freeze
  • high dose chemo → eradicate BM
  • reinfuse stem cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is autologous stem cell transplant used for?

A
  • Acute leukaemia
  • Solid tumours
  • Autoimmune disease

also , as allogeneic dangerous for following pop (high transplant related mortality)
Myeloma/ lymphoma/ CLL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Describe the process of allogeneic stem cell transplant

A
  • high dose chemoradiotherapy to ablate BM (malignant and normal cells)
  • then give BM from healthy donor
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

When should allogenic stem cell transplant be used?

A

Bone marrow failure

when patient’s disease unlikely to be eradicated from BM by standard chemotherapy

  • Acute leukaemia
  • Chronic leukaemia
  • Thalassaemia
  • Myeloma
  • Lymphoma
  • SCD
  • Bone marrow failure
  • Congenital immune deficiencies
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Main difference between autologous and allogenic SCT

A

Autologous HSCT → goal to kill all leukaemia with radio/chemo

Allogenic HSCT → accepted you cannot kill leukaemia from radio/chemo → rely on BM from donor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What type of infections can you get with BM transplantation?

A

organism depends on time after transplant

  • bacterial - when pt neutropenic (<30 days)
  • viral - dependent on total recovery of lymphocytes and macrophages (up to 1 yr)
  • fungus - candida early
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are some common causes of bacterial infection after BM transplant?

A

most common - gram positive (skin - e.g. staph epidermis)

but most deaths from sepsis gram neg (gut - e coli, pseudomonas, aeruginosa)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are some common causes of viral infection after BM transplant?

A

CMV (pneumonitis/retinitis/gastritis/colitis/encephalitis)
ABV, resp. PAPOVA, adenovirus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is graft vs host disease?

A

immune response when donor cells recognise patient as foreign

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Pathophysiology of GvHD

A
  • high dose chemo → cell damage → cytokine storm
  • cytokines activate APCs → present Ag to donor lymphocytes
  • → immune reaction against host tissue
  • could wait for longer after chemo for effects to die down before giving stem cell transplant - but increases time susceptible to infection

NB - GvHD happens v soon after transplant - so likely due to mature lymphocytes in donor sample rather than lymphocytes produced from stem cells

17
Q

S/S of acute GvHD

A

<100days

Skin rash, itchy, red

GI tract diarrhoea

Liver hepatitis, jaundice

18
Q

S/S of chronic GvHD

A

>100 days – similar to Sjögren’s

  • Skin rash
  • Liver hepatitis, jaundice
  • Mucosal membranes dry, mouth ulcers
  • Lungs SoB
  • Eyes dry
  • Joints arthritis
19
Q

treatment for GvHD

A

Corticosteroids

Calcineurin inhibitors (tacrolimus, cyclosporin A, sirolimus)

Mycophenolate mofetil

Monoclonal antibodies

Photopheresis

Total lymphoid irradiation

Mesenchumal stromal cells

20
Q

prevention of GvHD

A

immunosuppressing patients

  • methotrexate
  • corticosteroids
  • Cs A + MTX
  • Calcineurin inhibitors (tacrolimus, cyclosporin A, sirolimus)
  • T cell depletion
  • Post-transplant cyclophosphamide
21
Q

Describe T cell depletion

A

remove T cells from stem cell product before giving to pt

ex-vivo: monocloncal Ab aginst T cells → kills lymphocytes

but pts with TCD relapsed → but more donor lymphocytes restores remission → graft vs leukaemia effect

With lymphocytes = infection control, no leukaemia relapse, GvHD

Removing lymphocytes = infection (CMV), leukaemia relapse, no GvHD

22
Q

Transplant outcome is measured using this risk score

A

EBMT risk score:

23
Q

What is the strongest prognostic factor for cGvHD?

A

prior acute GvHD